| assessment year |
phenotype |
2 |
2 |
year of first personality assessment |
| associated SNPs |
cohort |
2 |
82 |
SNPs |
| associative learning |
phenotype |
3 |
2 |
|
| assortative mating |
phenotype |
2 |
2 |
|
| asthma |
phenotype |
19 |
8 |
asthmatics, children's asthma, doctor diagnosis of asthma, doctor-diagnosed asthma, reported asthma |
| ASTN2 |
gene |
3 |
3 |
Astrotactin 2 |
| astrocytes |
phenotype |
24 |
15 |
astrocyte, astrocyte reactivity, astrocyte subclusters, astrocytes, astrocytic, astroglia, border-forming reactive astrocytes, reactive astrocyte, reactive astrocytes |
| ASW |
cohort |
6 |
4 |
African American population, African Ancestry in Southwest USA, African ancestry (1KG Phase 1), African ancestry in Southwest USA, African-American (ASW) |
| asymmetry |
phenotype |
2 |
1 |
|
| ATAC-seq |
drug |
13 |
4 |
ATAC, ATAC-seq OCR |
| ataxia |
phenotype |
13 |
8 |
ataxic |
| ataxic effect |
phenotype |
4 |
1 |
ataxia, ataxic effects |
| ATF4 |
gene |
4 |
4 |
|
| atherosclerosis |
phenotype |
8 |
3 |
|
| ATM |
gene |
9 |
1 |
AT M, ATM, ATM gene, ATM protein, Ataxia Telangiectasia Mutated, Ataxia telangiectasia mutated, P-ATM, ataxia telangiectasia mutated, phospho-ATM |
| atomoxetine |
drug |
3 |
2 |
|
| Atopic dermatitis |
phenotype |
4 |
2 |
AD, eczema |
| ATP |
drug |
11 |
4 |
Epicentre ATP, Illumina ATP, adenine triphosphate, unlabeled ATP |
| ATP2A1 |
gene |
2 |
2 |
ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 1 |
| ATP2C2 |
gene |
2 |
2 |
ATPase, Ca2+-transporting, type 2C, member 2, Ca2+ transporting ATPase type 2C member 2 |
